Glyx Therapeutics
Glyx Therapeutics is at the forefront of the development of lipid-linked anionic oligosaccharides (LAOs) for the treatment of tauopathies, including Alzheimer’s disease. This innovative approach offers a promising alternative to…
Glyx Therapeutics is at the forefront of the development of lipid-linked anionic oligosaccharides (LAOs) for the treatment of tauopathies, including Alzheimer’s disease. This innovative approach offers a promising alternative to…
GnRHope Therapeutics aims to launch to market a pulsatile gonadotropin-releasing hormone (GnRH) therapy for patients suffering from cognition deficits (due to chromosomal abnormalities (Prader-Willi, Down Syndrom), or age-related cognitive decline),…
InVenis Biotherapies is a biotech compagny developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving…
Omniscience develops a SaaS solution for clinical trial management, enabling the collection, monitoring, control and analysis of patient status and the progress of both investigational and promotional studies in a…